"FDA has approved the trade name Firmagon for degarelix for injection, a gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the treatment of advanced prostate cancer."
Obviously 'Hardongone' ( great name for an anti-androgen ) was a little too obvious but they sneaked 'Firmagon' through FDA approval.
No comments:
Post a Comment